WINNERS & LOSERS: Allergy Therapeutics shares plunge on AIM exit plan
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday. Read More
| Price | 9.05p on 10-11-2026 at 19:15:11 |
|---|---|
| Change | -0.05p -0.55% |
| Buy | 9.08p |
| Sell | 9.05p |
| Last Trade: | Buy 381.00 at 9.05p |
| Day's Volume: | 558,229 |
| Last Close: | 9.05p |
| Open: | 9.11p |
| ISIN: | GB0008025412 |
| Day's Range | 9.05p - 9.15p |
| 52wk Range: | 6.72p - 10.70p |
| Market Capitalisation: | £104.60m |
| VWAP: | 9.123145p |
| Shares in Issue: | 1.16b |
SIG (SHI) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 381 | 9.05p | Suspected BUY Trade |
16:35:22 - 10-Nov-26 |
| Sell* | 139 | 9.05p | Automatic Execution |
16:21:30 - 10-Nov-26 |
| Buy* | 17 | 9.08p | SI Trade |
16:21:29 - 10-Nov-26 |
| Sell* | 553 | 9.0506p | Ordinary |
15:40:01 - 10-Nov-26 |
| Sell* | 102 | 9.05p | Automatic Execution |
14:52:30 - 10-Nov-26 |
| Sell* | 101 | 9.05p | Automatic Execution |
14:51:30 - 10-Nov-26 |
| Buy* | 4,821 | 9.09p | Automatic Execution |
14:51:04 - 10-Nov-26 |
| Sell* | 13,776 | 9.09p | Automatic Execution |
14:51:04 - 10-Nov-26 |
| Sell* | 2,666 | 9.0986p | Ordinary |
14:15:48 - 10-Nov-26 |
| Sell* | 50,000 | 9.10p | Automatic Execution |
12:08:35 - 10-Nov-26 |
SIG (SHI) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 22nd Oct 2026 3:31 pm | RNS | Director/PDMR Shareholding |
| 21st Oct 2026 7:00 am | RNS | NED & Chair of Audit & Risk Committee Appointment |
| 14th Oct 2026 4:08 pm | RNS | Director/PDMR Shareholding |
| 9th Oct 2026 7:00 am | RNS | Chief Executive succession |
| 5th Oct 2026 3:51 pm | RNS | Director/PDMR Shareholding |
| 17th Aug 2026 4:19 pm | RNS | Holding(s) in Company |
| 6th Aug 2026 4:30 pm | RNS | Holding(s) in Company |
| 4th Aug 2026 7:00 am | RNS | Results for the six months to 30 June 2026 |
| 16th Jul 2026 7:08 am | RNS | Post-close Trading Update |
| 8th Jun 2026 4:44 pm | RNS | Director/PDMR Shareholding |